-
1
-
-
0034186366
-
Prodrug activation enzymes in cancer gene therapy
-
Aghi M, Hochberg F, Breakefield XO. Prodrug activation enzymes in cancer gene therapy. J Gene Med. 2000;2:148-164.
-
(2000)
J Gene Med
, vol.2
, pp. 148-164
-
-
Aghi, M.1
Hochberg, F.2
Breakefield, X.O.3
-
2
-
-
0027523517
-
A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase
-
Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 1993;43:380-387.
-
(1993)
Mol Pharmacol
, vol.43
, pp. 380-387
-
-
Austin, E.A.1
Huber, B.E.2
-
3
-
-
0016790323
-
Mode of action of 5-fluorocytosine and mechanisms of resistance
-
Polak A, Scholer HJ. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21:113-130.
-
(1975)
Chemotherapy
, vol.21
, pp. 113-130
-
-
Polak, A.1
Scholer, H.J.2
-
4
-
-
0026599586
-
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system
-
Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 1992;89:33-37.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 33-37
-
-
Mullen, C.A.1
Kilstrup, M.2
Blaese, R.M.3
-
5
-
-
0027483695
-
The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
-
Freeman SM, Abboud CN, Whartenby KA, et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274-5283.
-
(1993)
Cancer Res
, vol.53
, pp. 5274-5283
-
-
Freeman, S.M.1
Abboud, C.N.2
Whartenby, K.A.3
-
6
-
-
0028108469
-
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
-
Huber BE, Austin EA, Richards CA, et al. Metabolism of 5- fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA. 1994;91:8302-8306.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8302-8306
-
-
Huber, B.E.1
Austin, E.A.2
Richards, C.A.3
-
7
-
-
0034117480
-
Gene therapy of experimental brain tumors using neural progenitor cells
-
Benedetti S, Pirola B, Polio B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 2000;6:447-450.
-
(2000)
Nat Med
, vol.6
, pp. 447-450
-
-
Benedetti, S.1
Pirola, B.2
Polio, B.3
-
8
-
-
0032527592
-
Generation and characterization of embryonic striatal conditionally immortalized ST14A cells
-
Cattaneo E, Conti L. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res. 1998;53:223-234.
-
(1998)
J Neurosci Res
, vol.53
, pp. 223-234
-
-
Cattaneo, E.1
Conti, L.2
-
9
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J lmmunol Methods. 1983;65:55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
11
-
-
0027977970
-
Metabolic suicide genes in gene therapy
-
Mullen CA. Metabolic suicide genes in gene therapy. Pharmacol Ther. 1994;63:199-207.
-
(1994)
Pharmacol Ther
, vol.63
, pp. 199-207
-
-
Mullen, C.A.1
-
12
-
-
0029943796
-
Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine
-
Haberkorn U, Oberdorfer F, Gebert J, et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med. 1996;37:87-94.
-
(1996)
J Nucl Med
, vol.37
, pp. 87-94
-
-
Haberkorn, U.1
Oberdorfer, F.2
Gebert, J.3
-
13
-
-
0033869563
-
Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
-
Vermes A, Guchelaar H-J, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171-179.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 171-179
-
-
Vermes, A.1
Guchelaar, H.-J.2
Dankert, J.3
-
14
-
-
0032892110
-
Reduced connexin43 expression in high-grade human brain glioma cells
-
Huang RP, Hossain MZ, Sehgal A, et al. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol. 1999;70:21-24.
-
(1999)
J Surg Oncol
, vol.70
, pp. 21-24
-
-
Huang, R.P.1
Hossain, M.Z.2
Sehgal, A.3
-
15
-
-
0032875678
-
Gap junction intercellular communication in gliomas is inversely related to cell motility
-
McDonough WS, Johansson A, Joffee H, et al. Gap junction intercellular communication in gliomas is inversely related to cell motility. Int J Dev Neurosci. 1999;17:601-611.
-
(1999)
Int J Dev Neurosci
, vol.17
, pp. 601-611
-
-
McDonough, W.S.1
Johansson, A.2
Joffee, H.3
-
16
-
-
15844409182
-
Protein and messenger RNA expression of connexin 43 in astrocytomas: Implications in brain tumor gene therapy
-
Shinoura N, Chen L, Wani MA, et al. Protein and messenger RNA expression of connexin 43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg. 1996;84:839-846.
-
(1996)
J Neurosurg
, vol.84
, pp. 839-846
-
-
Shinoura, N.1
Chen, L.2
Wani, M.A.3
-
17
-
-
0035131292
-
Expression of connexin-43 and functional gap junction coupling in human gliomas
-
Soroceanu L, Manning JT, Sontheimer H. Expression of connexin-43 and functional gap junction coupling in human gliomas. Glia. 2001;33:107-117.
-
(2001)
Glia
, vol.33
, pp. 107-117
-
-
Soroceanu, L.1
Manning, J.T.2
Sontheimer, H.3
-
18
-
-
0025972397
-
Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation
-
Zhu D, Caveney S, Kidder GM, et al. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl/Acad Sci USA. 1991;88:1883-1887.
-
(1991)
Proc Natl/Acad Sci USA
, vol.88
, pp. 1883-1887
-
-
Zhu, D.1
Caveney, S.2
Kidder, G.M.3
-
19
-
-
0343580476
-
Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum
-
Lundberg C, Martinez-Serrano A, Cattaneo E, et al. Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol. 1997;145:342-360.
-
(1997)
Exp Neurol
, vol.145
, pp. 342-360
-
-
Lundberg, C.1
Martinez-Serrano, A.2
Cattaneo, E.3
-
20
-
-
0034619328
-
Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
-
Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 2000;97:12846-12851.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 12846-12851
-
-
Aboody, K.S.1
Brown, A.2
Rainov, N.G.3
-
21
-
-
0028951119
-
Neural peogenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain
-
Snyder EY, Taylor RM, Wolfe JH. Neural peogenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374:367-370.
-
(1995)
Nature
, vol.374
, pp. 367-370
-
-
Snyder, E.Y.1
Taylor, R.M.2
Wolfe, J.H.3
|